Bitter pill: NPPA finds 312 drugs overcharging
Published on Thu, Jul 10, 2008 at 18:27 , Updated at Thu, Jul 10, 2008 at 23:29
Source : CNBC-TV18
| ads by google |
|
Messages on Business Talk
Other comments
IT cos may report sequential topline growth in Q2
The Street expects the frontline Indian IT companies to post a sequential topline growth ranging between 5.5-9.5 pe...
in Business Talk - MMB Messenger at 07-Oct-08 10:52
Is if safe to Play for Long term Or Short term ?
In todays market scenario what makes more sense : to be a long term investor or short term trader ? Source : www.tr...
in Business Talk - coolenough at 07-Oct-08 10:17
Rate this article
News
No News on Cadila Health
Notices
06-10 Cadila Healthcare Limited has infor...
23-09 Cadila Healthcare Limited has infor...
Expert Advice
No Expert Advice on Cadila Health
Management Interviews
No Management Interviews on Cadila Health
Brokerage Reports
03-10 Buy Cadila Healthcare, target of Rs...
04-09 Buy Cadila Healthcare: Motilal Oswa...
Technical Calls
No Technical Calls on Cadila Health
Chat
Ramesh Damani
Member BSE ,
(07 Oct- 16:30hrs)
What's good investment now?
Poll
Newsletter
Keep in touch with News day & night. Subscribe to:
Mobile Services
Get news on the move SMS to 52622
- SMS M for Market News
- SMS B for Latest Business News
- SMS S (stock name) for latest news




Online
Drug price regulator National Pharmaceutical Pricing Authority, or NPPA, has notifies overcharging cases on 312 drugs. The overcharging cases on companies include 




